EIP
Ellis Investment Partners’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9,511
| Closed | -$275K | – | 245 |
|
|
2024
Q3 | $275K | Sell |
9,511
-402
| -4% | -$11.6K | 0.05% | 198 |
|
|
2024
Q2 | $277K | Sell |
9,913
-576
| -5% | -$16.1K | 0.06% | 184 |
|
|
2024
Q1 | $291K | Sell |
10,489
-930
| -8% | -$25.8K | 0.06% | 179 |
|
|
2023
Q4 | $329K | Sell |
11,419
-8,812
| -44% | -$254K | 0.08% | 160 |
|
|
2023
Q3 | $671K | Sell |
20,231
-1,628
| -7% | -$54K | 0.17% | 102 |
|
|
2023
Q2 | $802K | Buy |
21,859
+1,915
| +10% | +$70.2K | 0.2% | 96 |
|
|
2023
Q1 | $814K | Buy |
19,944
+1,286
| +7% | +$52.5K | 0.21% | 94 |
|
|
2022
Q4 | $956K | Sell |
18,658
-370
| -2% | -$19K | 0.26% | 87 |
|
|
2022
Q3 | $832K | Buy |
19,028
+323
| +2% | +$14.1K | 0.23% | 91 |
|
|
2022
Q2 | $980K | Sell |
18,705
-2,468
| -12% | -$129K | 0.26% | 85 |
|
|
2022
Q1 | $1.1M | Buy |
21,173
+7,362
| +53% | +$381K | 0.26% | 82 |
|
|
2021
Q4 | $815K | Buy |
13,811
+7,179
| +108% | +$424K | 0.19% | 100 |
|
|
2021
Q3 | $285K | Sell |
6,632
-137
| -2% | -$5.89K | 0.07% | 174 |
|
|
2021
Q2 | $265K | Buy |
6,769
+61
| +0.9% | +$2.39K | 0.07% | 174 |
|
|
2021
Q1 | $243K | Sell |
6,708
-14
| -0.2% | -$507 | 0.07% | 176 |
|
|
2020
Q4 | $247K | Buy |
6,722
+358
| +6% | +$13.2K | 0.08% | 166 |
|
|
2020
Q3 | $233K | Buy |
6,364
+211
| +3% | +$7.73K | 0.08% | 154 |
|
|
2020
Q2 | $207K | Buy |
6,153
+2,435
| +65% | +$81.9K | 0.08% | 158 |
|
|
2020
Q1 | $118K | Sell |
3,718
-1,809
| -33% | -$57.4K | 0.06% | 171 |
|
|
2019
Q4 | $216K | Sell |
5,527
-411
| -7% | -$16.1K | 0.07% | 144 |
|
|
2019
Q3 | $210K | Sell |
5,938
-627
| -10% | -$22.2K | 0.08% | 144 |
|
|
2019
Q2 | $287K | Buy |
6,565
+52
| +0.8% | +$2.27K | 0.11% | 130 |
|
|
2019
Q1 | $279K | Buy |
6,513
+51
| +0.8% | +$2.19K | 0.11% | 130 |
|
|
2018
Q4 | $282K | Buy |
+6,462
| New | +$282K | 0.13% | 122 |
|